Abstract OBJECTIVE: Thoracic, arch, and proximal descending thoracic aorta diseases are still considered an enormous challenge. The hybrid approach developed in recent years (supra-aortic trunks debranching and thoracic endovascular repair aortic repair; TEVAR) may improve the morbidity and mortality of the population at risk. The aim of this study was to analyze retrospectively our experience in the hybrid treatment of aortic-arch aneurysms and dissections.
INTRODUCTION
Thoracic aortic disease affecting the arch and proximal descending thoracic aorta is still to be considered a challenge. In the past years, conventional surgical repair has been the only therapeutic method for extensive aortic diseases. However, this approach, which uses cardiopulmonary bypass, deep hypothermic circulatory arrest, retrograde cerebral perfusion, and anterograde cerebral perfusion, still carries a substantial rate of mortality and morbidity; furthermore, it predicts a high incidence of permanent neurological injury in old series (Table 1) . Good results require an accurate patient selection and high-volume activity but remain a challenge in elderly patients and in emergency scenarios. Hybrid procedures (HPs) and endovascular repair (thoracic endovascular repair aortic repair, TEVAR) combined with conventional open surgery (OS) to treat extensive aortic disease can be an alternative treatment and for, some patients, the new way of treatment. To date, HP remains an area of general debate.
MATERIALS AND METHODS
All combined approaches incorporating OS debranching and endovascular stent grafting between June 2005 and December 2010 were reviewed. Indications for the 27 patients included: 18 transverse arch aneurysms (10 saccular and six fusiform), four acute type B dissections associated with distal aneurysm, two subclavian artery aneurysms (one aberrant right subclavian artery aneurysm (ARSAA) [1] and one left subclavian artery (LSA) aneurysm), and three with penetrating aortic ulcers of the aortic arch. The primary end point of this retrospective study was to evaluate the clinical and technical success rate of HP. The clinical success was defined by the absence of perioperative aneurysmrelated death and aneurysm expansion or rupture. The technical success was defined by no intra-operative angiographic evidence of endoleaks, no graft infection or thrombosis, and no surgical conversion within the postoperatively 24 h. The secondary end point is to assess the morbidity/mortality rate and the complications/re-interventions' rate at 30 days.
Patient selection criteria
Surgical factor risks and significant medical co-morbidities were reported in Tables 2 and 3 , respectively. The exclusion criteria were a proximal or distal landing zone length <20 mm, circumferential calcifications or thrombus of proximal or distal landing zone, and inverted funnel-shaped proximal neck.
Preoperative planning
A duplex scan was performed in all patients to document the carotid and vertebral flow. Endograft procedures were planned preoperatively using computed tomography (CT) with multiplanar reconstruction by 3mensio Medical Imaging (3mensio Medical Imaging, BS Bilthoven, the Netherlands), which allows highly accurate measurements of true lumen diameter at the proximal landing zones (PLZs) level. The first stage consisted of supra-aortic trunks debranching to obtain an adequate PLZ for successful stent-graft deployment with a proper sealing. We planned the HP based on the anatomy of the aneurysm and the suitability of the proximal and distal landing zones, as reported in literature [2, 3] . Successful stent-graft deployment required a satisfactory PLZ ≥ 20 mm in length. The landing zones are classified according to the Ishimaru classification [3] and are reported in Table 4 . When feasible, the LSA revascularization was performed to prevent neurologic sequelae during TEVAR [4] .
Surgical debranching
Surgical strategy was based on the PLZ, which was needed to perform the endovascular deployment. All HPs were performed under general anesthesia. Different surgical procedures were performed before TEVAR and for the revascularization of the supra-aortic trunks. Surgical techniques are summarized in Table 5 .
Stent-graft deployment
Graft selection was made case-by-case based on the anatomy of the patient. The use of different TEVARs in different landing zones is reported in Table 5 . Generally, controlled hypotension (<80 mmHg) was used during the proximal deployment phase; the pacing technique was used twice. In patients with an inadequate iliac access, an arch anterograde approach for TEVAR deployment was used.
Management of the spinal-cord protection
Cerebrospinal fluid drainage (CSFD) was selectively used in chosen patients, who previously underwent open or endovascular abdominal aortic aneurysm repair and long aorta stent-graft covering (>20 cm in length), and who required prolonged mechanical ventilation that does not allow the early diagnosis of paraparesis or paraplegia. Postoperatively, the CSFD was selectively used at the It involves the mid-descending thoracic aorta.
onset of symptoms of anterior-spinal-cord ischemia. The drainage was set to a continuous pressure of 10 cmH 2 O to allow the CSF to drain freely, up to 30 ml h −1
. Regardless of the drainage placement, mean arterial pressure was perioperatively maintained at >90 mmHg with the use of inotropic drugs, when required.
Follow-up and statistical analysis
During the follow-up, patients received a chest X-ray and a CT scan of the chest with contrast agent. The exams were scheduled at 1, 6, and 12 months, and then yearly. Clinical examination of follow-up was performed at intervals of 6 months. Statistical analyses were performed by using the chi-square test, with Yates' correction to compare groups. The Fischer's exact test was used to analyze the small numbers. The level of significance was taken at p < 0.05. Data were recorded into a purpose-designed database by using Statistical Package for Social Sciences (SPSS) for Windows (SPSS Inc., Chicago, IL, USA).
RESULTS
A total of 27 patients (22 male, mean age 71.6 ± 5.6 SD years) with mean aneurysm diameter of 5.8 ± 1.7 SD cm (range, 2.7-9.6 cm) formed the study. Total urgent repair was performed in 18.5% (5/27) of cases: three patients presented pain and two others a frank rupture at the time of surgery. In emergency cases, the HP was performed simultaneously. In 36.3% of cases (8/22) performed electively, the TEVAR was deployed from 1 to 18 days after the surgical debranching. A retrograde transfemoral approach was used in 22 cases, in two cases through an iliacfemoral bypass grafting to allow the insertion of stent graft. In five patients, with inadequate retrograde access, an aortic-arch anterograde stent-graft access was used. Around one-tenth (11.1%) of patients (3/27) underwent open cardiac surgery prior to the HP. One patient underwent an ascending-aortic-prosthesis replacement due to the graft dilatation that was not adequate for stent-graft deployment. Two patients needed coronary artery bypass grafting (CABG). The mean number of stent grafts per case was 1.4 ± 0.6 SD (range, 1-3). The median device diameter was 36.3 ± 3.2 SD mm (range, 28-44). The distal placement of the aortic stent graft was above the sixth thoracic vertebra (T6) in 74.1% of cases (20/25) and below T6 in 25.9%. In 11 cases, an Amplatzer iliac plug was positioned (12 × 7 mm or 14 × 7 mm; AGA Medical, Golden Valley, MN, USA) into a subclavian artery to avoid the type II endoleak complication. Twelve patients (44.5%) needed sternotomy. No statistical difference in morbidity rate was found between patients who underwent sternotomy (ST) and those who did not receive it (NST) (66.7% (8/12) vs 53% (8/15); p = 0.4835). No statistical difference in mortality rate between the ST group and the NST group was found (25% (3/12) vs 20% (3/15); p = 0.7562).
Technical and clinical early outcomes
Technical success was achieved in 100% of cases. The perioperative mortality rate was 11.1% (3/27). Causes of death and major adverse events are reported in Table 6 . No aneurysm expansion or rupture was detected perioperatively. The 30-day rates of Case of ARSAA with anomalous origin of the supra-aortic trunks (the two CCAs come out together from the aorta, followed by the LSA and the aneurysm of the ARSA). death, stroke, and permanent paraplegia/paresis were 11.1%, 0%, and 0%, respectively.
Follow-up and late outcomes
The mean follow-up was 16.7 ± 18.1 SD months (range, 1-56 months). Late mortality was 14.8% (4/27). The overall death was 25.9% (7/27). The mean intensive care unit stay and mean length of hospital stay with the overall outcomes are summarized in Table 7 . The incidence of endoleak at follow-up was 3.7% (1/27). We detected a proximal type I endoleak due to TEVAR migration after 6 months' follow-up. We did not treat the patient because of his poor condition due to lung cancer in terminal phase. Midterm survival rate was 74% (20/27) at a mean follow-up of 16.7 months. Four patients died during the follow-up due to: one aneurysm rupture, one heart failure, and two lung infections. No statistical difference in term of survival rate was detected between the different PLZ treatments (Mantel-Cox p = 0.375; Breslow-Wilcoxon p = 0.553; Tarone-Ware p = 0.461; Fig. 1 ).
DISCUSSION
Although the HP appears to be an appealing concept in literature, there are no verified studies, and the decision to embark on a HP depends on the clinician's individual judgment and experience. Most authors advocate that hybrid-aortic-arch repair is reserved for high-risk surgical patients, who are unsuitable for conventional treatment due to significant perioperative morbidity and mortality. Many articles report a total endovascular solution through fenestrated, branched grafts and chimney grafts to treat the aortic-arch diseases [5, 6] , but current solutions have been reported in case reports or small case series, and they represent an approach that must be considered purely as experimental. Previous studies [7] suggested that HP of the aortic arch carries significant risks of death, stroke, and paraplegia with worse results for more proximal procedures. Nowadays, conventional OS of extensive aortic-arch disease remains the treatment of choice even if there are no excellent results for high-risk patients. Based on the series reported in literature, a direct comparison between conventional OS and hybrid ones is very difficult due to the following reasons: different operative techniques, different risk-stratification systems, and no uniform inclusion criteria and indications. Moreover, the outcomes should be read carefully as the high-risk patients are excluded from OS. However, it is reported that the incidence of perioperative mortality is between 3% and 22% in studies of aortic-arch OS and between 0% and 25% in case of hybrid-aortic-arch procedures [8] .
In our series, hybrid-aortic-arch repair was reserved for high-risk surgical patients, with an acceptable perioperative mortality (30 days) of 11.1% and worst results of complications (51.8%). HPs generally are considered minimally invasive, but, in many cases, the procedures still involve large incisions (sternotomies and/or laparatomies). Twelve of 27 (44.5%) of our patients needed sternotomy. In literature, some authors suggest to use the 'mini' thoracotomy approach [9] ; we did not adopt this method due to the fact that we preferred to have better control of the arch aortic and of the large supra-aortic vessels. When feasible, we always revascularized the LSA, because we reckon that LSA revascularization proves to prevent neurologic sequelae during TEVAR. Studies by the European Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair (EUROSTAR) [4] suggested that revascularization of LSA was not protective toward stroke, but recent and numerous others studies showed that not revascularizing LSA was seen as a risk factor for stroke [10, 11] . The paraplegia and paraparesis rates reported in literature are between 1.5% and 7% after TEVAR and HP [8] [9] [10] [11] [12] , while after OS they increase between 1.4% and 14% [13, 14] . Flores identified predictors of spinal-cord ischemia and paraplegia in patients undergoing the 'frozen' stented elephant-trunk technique [15] . In his series, paraplegia occurred in 24% of the cases (6/25 patients). The combination of a distal landing zone of T7 or greater and a history of abdominal aortic aneurysm repair was the strongest predictor of spinal-cord injury. Holt et al. [16] showed that LSA coverage without revascularization is associated with a higher combined rate of death, stroke, and paraplegia. In our series, the incidence of temporary spinal-cord ischemia and paraplegia immediately after surgery was 3.7% (1/27), and it completely regressed 48 h after CSFD. The small numbers of our series do not allow us to draw statistically significant conclusions.
LIMITATION OF THE STUDY
This work presents some bias: absence of surgical control group, a series with small numbers of patients, a non-consecutive retrospective study, circle of Willis patency and completeness were not routinely assessed, and no control group without LSA revascularization.
CONCLUSION
HP of complex-aortic-arch disease could be an alternative treatment option for patients with high risk for conventional OS. Acceptable results can be achieved. No long-term data exist to ascertain the durability of this method. The hybrid arch repair for aortic-arch aneurysms continues to evolve and only increasing experience might reduce morbid-mortality, but the results must be measured against the ones achieved through OS techniques. Data remain limited, and we must be cautious in our enthusiastic espousal of this new technology. Further comparative studies are required to consolidate the outcomes of this treatment and define its role in the management of extensive aortic disease.
